Lovaza
Product Images NDC 21695-795

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Lovaza (NDC 21695-795). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rebel Distributors Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Epa Chemical Structure (7892fb39 94c6 41cc B8cd D9d145180a96 01)

Chemical structure diagram showing the molecular structure of the active ingredient related to LOVAZA, illustrating the arrangement of bonds and functional groups in the molecule.*

FDA Label Image

Dha Chemical Structure (7892fb39 94c6 41cc B8cd D9d145180a96 02)

Chemical structure of the active ingredient shown on the LOVAZA product image.*

FDA Label Image

Lovaza 1gm (7892fb39 94c6 41cc B8cd D9d145180a96 03)

Packaging label for LOVAZA 1gm capsules, containing 120 capsules per package. Label states each capsule contains 1gm omega-3-acid ethyl ester liquid concentrate, with at least 900mg omega-3-acid ethyl esters. Distributed by Physician Partner and manufactured by Catalent Pharma Solutions and Accucaps Industries. Includes NDC 21695-795-72.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.